-
Research archive
Page…information about the study can be found HERE >>. The FinFluHD influenza vaccine trial was conducted between 2018 and 2022 in collaboration with Sanofi Pasteur. It involved more than 33,000 subjects during the 2019–2020 flu season, but due to the COVID-19 pandemic, the study was…
-
Our role
Page…the utilization of national health registers. These studies will search for additional data on the effectiveness and potential side effects of vaccines after a commercial license has been obtained. The studies are based on real-world information and help with understanding the effects of vaccines in…
-
In category Blog
Vaccine development thrives – Finland offers unique possibilities
Post…cost implications, the costs of administering the vaccine, and the effectiveness of the vaccine in routine use. The decision on the inclusion on a vaccination program requires an assessment of how much the program can reduce the total number of cases in the target group….
-
About cookies
Page…this either through the cookie banner, on this page, or in your browser settings. We use the information to compile anonymous statistics and aggregate reports for internal use and for the partners and subcontractors who are involved in the development of our content. FVR –…
-
References for post-licensure studies
Page…foreign citizens residing in Finland on a permanent basis. The information in the system is used throughout the information services and management of the Finnish society. Personal data recorded in the system includes e.g. the date and country of birth, date of death (if applicable),…
-
BoD and management
Page…She has been one of the founders of two biotech companies: BioTie Therapies and Faron Pharmaceuticals. Positions of Trust: Chairperson of the Board: Cancer Foundation Finland and Emil Aaltonen Foundation. Board member: Association of Finnish Foundations, Science Foundation of the Microbiologists of Turku. Board member: Orion…
-
In category Blog
Conducting successful clinical trials for influenza vaccines
Post…no compromise to the quality of the data. 1. Successful enrollment and availability of study participants Misconceptions or lack of vaccine awareness is one of the biggest hurdles in the enrollment of volunteers for studies. Another is the lack of sufficient outreach/public relations strategies of…
-
Sustainability: focus on people’s wellbeing and safety
Page…by the end of 2024 (certification 2025) ENVIRONMENT Energy consumption Baseline analysis done and goals set by the end of 2024 Travel Baseline analysis done and goals set by the end of 2024 Procurement Sustainability criteria defined and implemented for procurement by the end of…
-
In category News
FVR strengthens its future operations and growth potential through organizational restructuring
Post…of Health and Welfare (THL). The Finnish state owns 51% of the company and the Tampere University Foundation 49%. The Ministry of Social Affairs and Health (STM) is responsible for the ownership steering of the company. In 2023, FVR employed 114 professionals at 10 clinics…
-
In category News
FVR joins ImmuDocs doctoral pilot project to increase immunology expertise in Finland
Post…the ImmuDocs pilot project. The consortium partners of the pilot are the University of Turku, Åbo Akademi University, the University of Helsinki, the University of Oulu, the University of Eastern Finland, the University of Tampere, FVR, and the Wellbeing Services County of Southwest Finland. The…
-
In category Press releases
Finnish research expertise utilizing national register data produces internationally unique information
Post…team of the Finnish Institute of Health and Welfare (THL), which in 2022 became part of the special-assignment company of the state: FVR – Finnish Vaccine Research Ltd. The study was carried out in cooperation with the vaccine manufacturer Sanofi. The use of national registers,…
-
In category News
FVR – Finnish Vaccine Research Ltd’s employee cooperation and change negotiations have been concluded
Post…its future operations and growth potential in the global competitive market for vaccine research. As a result of the negotiations, the company will open a new, larger site in Helsinki by combining the current two small clinics. The new clinic will open on February 1,…